140 related articles for article (PubMed ID: 32716404)
1. Quantitative bone SPECT/CT applications for cartilaginous bone neoplasms.
Kitajima K; Futani H; Tsuchitani T; Takahashi Y; Tachibana T; Yamakado K
Hell J Nucl Med; 2020; 23(2):133-137. PubMed ID: 32716404
[TBL] [Abstract][Full Text] [Related]
2. Quantitative bone SPECT/CT applications for primary bone neoplasms.
Kitajima K; Futani H; Komoto H; Tsuchitani T; Takahashi Y; Tachibana T; Yamakado K
Hell J Nucl Med; 2021; 24(1):36-44. PubMed ID: 33866337
[TBL] [Abstract][Full Text] [Related]
3. The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases.
Zhang Y; Li B; Yu H; Song J; Zhou Y; Shi H
Nucl Med Commun; 2021 Jan; 42(1):63-67. PubMed ID: 33044406
[TBL] [Abstract][Full Text] [Related]
4. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
Jpn J Radiol; 2022 May; 40(5):492-499. PubMed ID: 34851501
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study.
Motegi K; Matsutomo N; Yamamoto T; Koizumi M
Radiol Phys Technol; 2020 Sep; 13(3):219-229. PubMed ID: 32535819
[TBL] [Abstract][Full Text] [Related]
7. Standardized uptake values of
Qi N; Meng Q; You Z; Chen H; Shou Y; Zhao J
BMC Med Imaging; 2021 Feb; 21(1):39. PubMed ID: 33639883
[TBL] [Abstract][Full Text] [Related]
8. Quantitative SPECT/CT for differentiating between enchondroma and grade I chondrosarcoma.
Choi WH; Han EJ; Chang KB; Joo MW
Sci Rep; 2020 Jun; 10(1):10587. PubMed ID: 32601314
[TBL] [Abstract][Full Text] [Related]
9.
Annovazzi A; Anelli V; Zoccali C; Rumi N; Persichetti A; Novello M; Sciuto R; Bertoni F; Ferraresi V; Biagini R
Ann Nucl Med; 2019 Nov; 33(11):813-821. PubMed ID: 31396797
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
Okui T; Kobayashi Y; Tsujimoto M; Satoh K; Toyama H; Matsuo K
Ann Nucl Med; 2020 Sep; 34(9):620-628. PubMed ID: 32557015
[TBL] [Abstract][Full Text] [Related]
11. Test-retest repeatability of quantitative bone SPECT/CT.
Yamane T; Fukushima K; Shirotake S; Nishimoto K; Okabe T; Oyama M; Seto A; Kuji I
Ann Nucl Med; 2021 Mar; 35(3):338-346. PubMed ID: 33400148
[TBL] [Abstract][Full Text] [Related]
12. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
Ogura I; Kobayashi E; Nakahara K; Igarashi K; Haga-Tsujimura M; Toshima H
Ann Nucl Med; 2019 Oct; 33(10):776-782. PubMed ID: 31342316
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response.
Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
Jpn J Radiol; 2023 Jul; 41(7):760-767. PubMed ID: 36656541
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging-Based Grading of Cartilaginous Bone Tumors: Added Value of Quantitative Texture Analysis.
Fritz B; Müller DA; Sutter R; Wurnig MC; Wagner MW; Pfirrmann CWA; Fischer MA
Invest Radiol; 2018 Nov; 53(11):663-672. PubMed ID: 29863601
[TBL] [Abstract][Full Text] [Related]
15. Radiographic Enchondroma Surveillance: Assessing Clinical Outcomes and Costs Effectiveness.
Akoh CC; Craig E; Troester AM; Miller BJ
Iowa Orthop J; 2019; 39(1):185-193. PubMed ID: 31413693
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
Lee FY; Yu J; Chang SS; Fawwaz R; Parisien MV
J Bone Joint Surg Am; 2004 Dec; 86(12):2677-85. PubMed ID: 15590853
[TBL] [Abstract][Full Text] [Related]
17. Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients.
Mohd Rohani MF; Mat Nawi N; Shamim SE; Wan Sohaimi WF; Wan Zainon WMN; Musarudin M; Said MA; Hashim H
Ann Nucl Med; 2020 Jan; 34(1):39-48. PubMed ID: 31612417
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of quantitative bone SPECT/CT for bone metastasis diagnosis.
Ikeda T; Kitajima K; Tsuchitani T; Takahashi Y; Hama Y; Kotura N
Hell J Nucl Med; 2022; 25(3):253-259. PubMed ID: 36507881
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients.
Umeda T; Koizumi M; Fukai S; Miyaji N; Motegi K; Nakazawa S; Takiguchi T
Ann Nucl Med; 2018 Feb; 32(2):105-113. PubMed ID: 29243019
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
